Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Physiol., 14 August 2025

Sec. Cardiac Electrophysiology

Volume 16 - 2025 | https://doi.org/10.3389/fphys.2025.1672433

Correction: Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation

This article is a correction to:

  1. Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation

    1. Read original article
Bastien Guillot,&#x;Bastien Guillot1,2†Arthur Boileve,&#x;Arthur Boileve3,4†Richard Walton,Richard Walton1,2Alexandre Harfoush,Alexandre Harfoush3,4Caroline Conte,Caroline Conte5,6Yannis Sainte-Marie,Yannis Sainte-Marie5,6Sabine Charron,Sabine Charron1,2Olivier Bernus,Olivier Bernus1,2Alice Recalde,&#x;Alice Recalde1,2‡Laurent Sall,&#x;Laurent Sallé3,4‡Fabien Brette,, &#x;Fabien Brette1,2,7*‡Frank Lezoualc&#x;h,&#x;Frank Lezoualc’h5,6‡
  • 1IHU LIRYC -CRCTB U1045, Pessac, France
  • 2INSERM U1045 -Université de Bordeaux, Bordeaux, France
  • 3UR 4650 PSIR, GIP Cyceron, Caen, France
  • 4Université de Caen-Normandie, Caen, France
  • 5Université de Toulouse-Paul Sabatier, Toulouse, France
  • 6Institut des maladies métaboliques et cardiovasculaires, INSERM UMR-1297, Toulouse, France
  • 7PhyMedExp, INSERM U1046, CNRS 9412, Université de Montpellier, Montpellier, France

A Correction on
Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation

by Guillot B, Boileve A, Walton R, Harfoush A, Conte C, Sainte-Marie Y, Charron S, Bernus O, Recalde A, Sallé L, Brette F and Lezoualc’h F (2023). Front. Physiol. 14:1120336. doi: 10.3389/fphys.2023.1120336

In the published article, there was a mistake in the Funding statement. The funding statement for the ANR ELECTRO was displayed as “ANR-19-CE17-0010 (ELECTRO)”. The correct statement appears below.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by research grants from the French National Funding Agency for Research (ANR) 10-IAHU-04 and ANR-20-CE17-0010 (ELECTRO). Fondation pour la Recherche Médicale (FL’h, Programme “Equipes FRM 2021”) and from Normandie Region (FEDER RIN EMERGENT EPAF—2020DRI00234). AR was supported by a grant from “Fonds FGLMR/AVAD pour les Maladies Chroniques”. AB and AH are recipients of a doctoral and postdoctoral fellowships from ANR ELECTRO and RIN FEDER EPAF, respectively.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: EPAC, atrial fibrillation, optical mapping, cardiomyocytes, action potential

Citation: Guillot B, Boileve A, Walton R, Harfoush A, Conte C, Sainte-Marie Y, Charron S, Bernus O, Recalde A, Sallé L, Brette F and Lezoualc’h F (2025) Correction: Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation. Front. Physiol. 16:1672433. doi: 10.3389/fphys.2025.1672433

Received: 24 July 2025; Accepted: 28 July 2025;
Published: 14 August 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Guillot, Boileve, Walton, Harfoush, Conte, Sainte-Marie, Charron, Bernus, Recalde, Sallé, Brette and Lezoualc’h. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Fabien Brette, ZmFiaWVuLmJyZXR0ZUBpbnNlcm0uZnI=

†These authors have contributed equally to this work and share first authorship

‡These authors have contributed equally to this work and share last authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.